CLINICAL SUPPLY MANUFACTURING ARTICLES

FDA-GettyImages-679546546 Understanding FDA's Draft Guidance On Human- And Animal-Derived Materials In The Manufacture Of Cell & Gene Therapy Products

FDA has released the new draft guidance for industry, Considerations for the Use of Human- and Animal-Derived Materials in the Manufacture of Cellular and Gene Therapy and Tissue-Engineered Medical Products. This article provides a summary — and shares what is shocking about the guidance.

CLINICAL SUPPLY MANUFACTURING VIDEOS

Susan Dexter, Chief Technical Officer, Sonnet BioTherapeutics, describes the good choices she made, and one not-so-good choice, in trying to untie a knotted supply chain.

Expert speakers discuss current operational obstacles and explore strategic solutions to optimize a supply chain strategy in the years ahead.

Early planning mitigates risk by avoiding stock outs and study delays, minimizing waste with optimized inventory, and forecasting demand to facilitate robust supply planning.

Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.

CLINICAL SUPPLY MANUFACTURING RESOURCES